VEGF and p53 in Oesophageal Cancer
Author Information
Author(s): S Uchida, Y Shimada, G Watanabe, H Tanaka, I Shibagaki, T Miyahara, S Ishigami, S Arii, M Imamura
Primary Institution: Kyoto University
Hypothesis
Does vascular endothelial growth factor (VEGF) expression correlate with p53 mutation and affect prognosis in oesophageal squamous cell carcinoma?
Conclusion
VEGF expression is associated with p53 mutation, advanced cancer stage, and poorer prognosis in oesophageal squamous cell carcinoma.
Supporting Evidence
- 59.6% of the tumors were classified as VEGF positive.
- VEGF expression correlated significantly with the depth of invasion and lymph node metastasis.
- Patients with VEGF-positive tumors had significantly worse prognoses than those with VEGF-negative tumors.
Takeaway
This study found that a protein called VEGF, which helps tumors grow blood vessels, is linked to a gene mutation and worse outcomes in patients with a type of throat cancer.
Methodology
The study examined 109 resected oesophageal squamous cell carcinomas for VEGF expression using immunohistochemical staining and analyzed correlations with p53 mutations and clinical factors.
Limitations
The study was limited to a specific patient population and may not generalize to all oesophageal cancer cases.
Participant Demographics
The participants included 88 males and 21 females, aged 43 to 84 years.
Statistical Information
P-Value
P = 0.0291
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website